Treatment of chronic immune thrombocytopenia in children with romiplostim

被引：1
|
作者：
Chaturvedi, Shruti [1 ]
McCrae, Keith R. [2 ,3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Dept Med, Nashville, TN USA
[2] Cleveland Clin, Dept Hematol & Oncol, Cleveland, OH 44195 USA
[3] Cleveland Clin, Cellular & Mol Med, Cleveland, OH 44195 USA
来源：
LANCET | 2016年 / 388卷 / 10039期
关键词：
CONTROLLED-TRIAL; ELTROMBOPAG; ITP; MULTICENTER; MANAGEMENT; REMISSION; EFFICACY; SAFETY;
D O I：
10.1016/S0140-6736(16)00589-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [1] Romiplostim for the treatment of adults with chronic immune thrombocytopenia
    Terrail, Nicolas
    [J]. EJHP PRACTICE, 2009, 15 (03): : 70 - 73
  • [2] Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia
    Mokhtar, Galila M.
    Tantawy, Azza A. G.
    El Sherif, Nayera H. K.
    [J]. PLATELETS, 2012, 23 (04) : 264 - 273
  • [3] Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience
    Pasquet, Marlene
    Aladjidi, Nathalie
    Guiton, Corinne
    Courcoux, Mary-France
    Munzer, Martine
    Auvrignon, Anne
    Lutz, Patrick
    Ducassou, Stephane
    LeRoy, Gwennaelle
    Munzer, Caroline
    Leverger, Guy
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (02) : 266 - 271
  • [4] ONE YEAR FOLLOW UP STUDY OF ROMIPLOSTIM IN THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA
    Mokhtar, G.
    Tantawy, A.
    Ragab, I.
    Hazaa, N.
    Gomaa, H.
    [J]. HAEMATOLOGICA, 2012, 97 : 689 - 689
  • [5] Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland
    Lee D.
    Thornton P.
    Hirst A.
    Kutikova L.
    Deuson R.
    Brereton N.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (5) : 457 - 469
  • [6] Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy
    Buchbinder, David
    Nugent, Diane
    Hsieh, Loan
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1055 - 1063
  • [7] Romiplostim as a treatment for immune thrombocytopenia: a review
    Chalmers, Sarah
    Tarantino, Michael D.
    [J]. JOURNAL OF BLOOD MEDICINE, 2015, 6 : 37 - 44
  • [8] Romiplostim for the treatment of primary immune thrombocytopenia
    Janssens, Ann
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (02) : 133 - 144
  • [9] Erratum to: Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
    Dawn Lee
    Patrick Thornton
    Alexander Hirst
    Lucie Kutikova
    Robert Deuson
    Nic Brereton
    [J]. Applied Health Economics and Health Policy, 2013, 11 (6) : 687 - 687
  • [10] COST-EFFECTIVENESS OF ROMIPLOSTIM FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN PORTUGAL
    Augusto, M.
    Gouveia, M.
    Borges, M.
    Campioni, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A532 - A532
12345